Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients.
Van Wigcheren GF, De Haas N, Mulder TA, Horrevorts SK, Bloemendal M, Hins-Debree S, Mao Y, Kiessling R, van Herpen CML, Flórez-Grau G, Hato SV, De Vries IJM. Van Wigcheren GF, et al. Among authors: van herpen cml. Oncoimmunology. 2021 Jun 27;10(1):1935557. doi: 10.1080/2162402X.2021.1935557. eCollection 2021. Oncoimmunology. 2021. PMID: 34239773 Free PMC article.
Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM, van der Laak JA, de Vries IJ, van Krieken JH, de Wilde PC, Balvers MG, Adema GJ, De Mulder PH. van Herpen CM, et al. Clin Cancer Res. 2005 Mar 1;11(5):1899-909. doi: 10.1158/1078-0432.CCR-04-1524. Clin Cancer Res. 2005. PMID: 15756016 Clinical Trial.
Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination.
Mulder SF, Jacobs JF, Olde Nordkamp MA, Galama JM, Desar IM, Torensma R, Teerenstra S, Mulders PF, Vissers KC, Punt CJ, de Vries IJ, van Herpen CM. Mulder SF, et al. Clin Cancer Res. 2011 Jul 1;17(13):4541-9. doi: 10.1158/1078-0432.CCR-11-0253. Epub 2011 Jun 28. Clin Cancer Res. 2011. PMID: 21712444 Free article. Clinical Trial.
Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity.
Hato SV, Figdor CG, Takahashi S, Pen AE, Halilovic A, Bol KF, Vasaturo A, Inoue Y, de Haas N, Verweij D, Van Herpen CML, Kaanders JH, van Krieken JHJM, Van Laarhoven HWM, Hooijer GKJ, Punt CJA, Asai A, de Vries IJM, Lesterhuis WJ. Hato SV, et al. Among authors: van laarhoven hwm, van herpen cml, van krieken jhjm. Oncotarget. 2017 May 7;8(33):54434-54443. doi: 10.18632/oncotarget.17661. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903353 Free PMC article.
Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathways.
van Wigcheren GF, Cuenca-Escalona J, Stelloo S, Brake J, Peeters E, Horrevorts SK, Frölich S, Ramos-Tomillero I, Wesseling-Rozendaal Y, van Herpen CML, van de Stolpe A, Vermeulen M, de Vries IJM, Figdor CG, Flórez-Grau G. van Wigcheren GF, et al. Among authors: van herpen cml. J Biol Chem. 2023 Nov;299(11):105276. doi: 10.1016/j.jbc.2023.105276. Epub 2023 Sep 20. J Biol Chem. 2023. PMID: 37739035 Free PMC article.
Long-term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: results of a multidisciplinary late morbidity clinic.
Rütten H, Pop LA, Janssens GO, Takes RP, Knuijt S, Rooijakkers AF, van den Berg M, Merkx MA, van Herpen CM, Kaanders JH. Rütten H, et al. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):923-9. doi: 10.1016/j.ijrobp.2010.07.013. Epub 2010 Nov 20. Int J Radiat Oncol Biol Phys. 2011. PMID: 21095074
256 results